Atlas Trials

Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED

Clinical trial NCT04338828 · TERMINATED

Trial details

NCT number
NCT04338828
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID19
Start date
2020-04-18
Primary completion
2021-01-14
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.